Professor of Epidemiology
University of Maryland
Johns Hopkins University
Drexel University email@example.com
Dr. Nash has over 20 years of expertise in implementation science, and his research consistently generates new knowledge with clear programmatic and policy implications. His experience includes extensive domestic and international work in implementation science, comparative effectiveness research and large-scale epidemiologic studies examining key outcomes among persons with HIV.
Dr. Nash brings seasoned expertise in study design and methodological approaches to large-scale, ‘real-world’, research projects. Prior to joining CUNY, Dr. Nash was an EIS Officer and subsequently the Director of HIV/AIDS Surveillance, where he pioneered named reporting for HIV. He also worked at ICAP at Columbia University as the Director of Monitoring, Evaluation and Research, spearheading a multi-country initiative collecting routine medical records electronically.
Dr. Nash has extensive global health implementation and research experience. He has worked extensively on large scale initiatives and research projects in sub-Saharan Africa, including on the Guinea Worm Eradication Program in Nigeria, sentinel HIV surveillance in Nigeria and Botswana, and rapid expansion/scale-up of HIV/AIDS care and treatment under the President’s Emergency Plan for AIDS Relief (PEPFAR) in Burundi, Cote d’Ivoire, Ethiopia, Kenya, Lesotho, Mozambique, Nigeria, Rwanda, South Africa, Swaziland, Tanzania, Uganda, and Zambia. He has recently begun a research project on non-communicable diseases, which includes household population health survey of 4 urban slums in Port au Prince, Haiti.
Gadisa T, Tymejczyk O, Kulkarni SG, Hoffman S, Lahuerta M, Remien RH, Yigzaw M, Daba S, Elul B, Nash D, Melaku Z. Disclosure History Among Persons Initiating Antiretroviral Treatment at Six HIV Clinics in Oromia, Ethiopia, 2012-2013. AIDS Behav. 2017 Jan;21(1):70-81. doi: 10.1007/s10461-016-1290-4.
Adedimeji A, Edmonds A, Hoover D, Shi Q, Sinayobye JD, Nduwimana M, Lelo P, Nash D, Anastos K, Yotebieng M. Characteristics of HIV-Infected Children at Enrollment into Care and at Antiretroviral Therapy Initiation in Central Africa. PLoS One. 2017 Jan 12;12(1): e0169871. doi: 10.1371/journal.pone.0169871. eCollection 2017.
Zürcher K, Mooser A, Anderegg N, Tymejczyk O, Couvillon MJ, Nash D, Egger M; IeDEA and MESH consortia. Outcomes of HIV-positive Patients Lost to Follow-up in African Treatment Programs. Trop Med Int Health. 2017 Jan 19. doi: 10.1111/tmi.12843. [Epub ahead of print]
Perlman DC, Jordan AE, Nash D. Conceptualizing Care Continua: Lessons from HIV, Hepatitis C Virus, Tuberculosis and Implications for the Development of Improved Care and Prevention Continua. Front Public Health. 2017 Jan 10;4:296. doi: 10.3389/fpubh.2016.00296. eCollection 2016.
Kimmel AD, Nash D. HIV prevention resources: time to move toward affordability. Lancet HIV. 2017 Feb 20. pii: S2352-3018(17)30022-X. doi: 10.1016/S2352-3018(17)30022-X. [Epub ahead of print]